Log in to save to my catalogue

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-...

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7455192305464eb3bbf777690aee4c38

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)

About this item

Full title

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)

Publisher

London: Wellcome Trust Limited

Journal title

Wellcome open research, 2020, Vol.5, p.160

Language

English

Formats

Publication information

Publisher

London: Wellcome Trust Limited

More information

Scope and Contents

Contents

Background:
 Dengue is a disease of major global importance. While most symptomatic infections are mild, a small proportion of patients progress to severe disease with risk of hypovolaemic shock, organ dysfunction and death.  In the absence of effective antiviral or disease modifying drugs, clinical management is solely reliant on supportive mea...

Alternative Titles

Full title

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7455192305464eb3bbf777690aee4c38

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7455192305464eb3bbf777690aee4c38

Other Identifiers

ISSN

2398-502X

E-ISSN

2398-502X

DOI

10.12688/wellcomeopenres.16053.1

How to access this item